285 related articles for article (PubMed ID: 22633187)
1. Lycopene for the prevention and treatment of benign prostatic hyperplasia and prostate cancer: a systematic review.
Ilic D; Misso M
Maturitas; 2012 Aug; 72(4):269-76. PubMed ID: 22633187
[TBL] [Abstract][Full Text] [Related]
2. Lycopene for the prevention of prostate cancer.
Ilic D; Forbes KM; Hassed C
Cochrane Database Syst Rev; 2011 Nov; 2011(11):CD008007. PubMed ID: 22071840
[TBL] [Abstract][Full Text] [Related]
3. Phytotherapeutic interventions in the management of biochemically recurrent prostate cancer: a systematic review of randomised trials.
van Die MD; Bone KM; Emery J; Williams SG; Pirotta MV; Paller CJ
BJU Int; 2016 Apr; 117 Suppl 4(Suppl 4):17-34. PubMed ID: 26898239
[TBL] [Abstract][Full Text] [Related]
4. Lycopene for the prevention and treatment of prostate disease.
Ilic D
Recent Results Cancer Res; 2014; 202():109-14. PubMed ID: 24531784
[TBL] [Abstract][Full Text] [Related]
5. Nutraceutical treatment and prevention of benign prostatic hyperplasia and prostate cancer.
Cicero AFG; Allkanjari O; Busetto GM; Cai T; Larganà G; Magri V; Perletti G; Robustelli Della Cuna FS; Russo GI; Stamatiou K; Trinchieri A; Vitalone A
Arch Ital Urol Androl; 2019 Oct; 91(3):. PubMed ID: 31577095
[TBL] [Abstract][Full Text] [Related]
6. The emerging anti-neoplastic effects of lycopene: beyond its role in prostate carcinomas.
Kapoor S
Maturitas; 2012 Dec; 73(4):373; author reply 374. PubMed ID: 23067956
[No Abstract] [Full Text] [Related]
7. Cernilton for benign prostatic hyperplasia.
Wilt T; Mac Donald R; Ishani A; Rutks I; Stark G
Cochrane Database Syst Rev; 2000; (2):CD001042. PubMed ID: 10796739
[TBL] [Abstract][Full Text] [Related]
8. Botanical derivatives for the prostate.
Cristoni A; Di Pierro F; Bombardelli E
Fitoterapia; 2000 Aug; 71 Suppl 1():S21-8. PubMed ID: 10930709
[TBL] [Abstract][Full Text] [Related]
9. Serenoa repens for benign prostatic hyperplasia.
Wilt T; Ishani A; Mac Donald R
Cochrane Database Syst Rev; 2002; (3):CD001423. PubMed ID: 12137626
[TBL] [Abstract][Full Text] [Related]
10. WITHDRAWN: Cernilton for benign prostatic hyperplasia.
Wilt TJ; Macdonald R; Ishani A; Rutks I; Stark G
Cochrane Database Syst Rev; 2011 May; 2011(5):CD001042. PubMed ID: 21563128
[TBL] [Abstract][Full Text] [Related]
11. Soy and soy isoflavones in prostate cancer: a systematic review and meta-analysis of randomized controlled trials.
van Die MD; Bone KM; Williams SG; Pirotta MV
BJU Int; 2014 May; 113(5b):E119-30. PubMed ID: 24053483
[TBL] [Abstract][Full Text] [Related]
12. Is there a benefit from lycopene supplementation in men with prostate cancer? A systematic review.
Haseen F; Cantwell MM; O'Sullivan JM; Murray LJ
Prostate Cancer Prostatic Dis; 2009; 12(4):325-32. PubMed ID: 19901932
[TBL] [Abstract][Full Text] [Related]
13. Dietary lycopene intake and risk of prostate cancer defined by ERG protein expression.
Graff RE; Pettersson A; Lis RT; Ahearn TU; Markt SC; Wilson KM; Rider JR; Fiorentino M; Finn S; Kenfield SA; Loda M; Giovannucci EL; Rosner B; Mucci LA
Am J Clin Nutr; 2016 Mar; 103(3):851-60. PubMed ID: 26817504
[TBL] [Abstract][Full Text] [Related]
14. Serenoa Repens, lycopene and selenium: a triple therapeutic approach to manage benign prostatic hyperplasia.
Minutoli L; Bitto A; Squadrito F; Marini H; Irrera N; Morgia G; Passantino A; Altavilla D
Curr Med Chem; 2013; 20(10):1306-12. PubMed ID: 23432584
[TBL] [Abstract][Full Text] [Related]
15. Antioxidant effects of lycopene in African American men with prostate cancer or benign prostate hyperplasia: a randomized, controlled trial.
van Breemen RB; Sharifi R; Viana M; Pajkovic N; Zhu D; Yuan L; Yang Y; Bowen PE; Stacewicz-Sapuntzakis M
Cancer Prev Res (Phila); 2011 May; 4(5):711-8. PubMed ID: 21430075
[TBL] [Abstract][Full Text] [Related]
16. Lycopene inhibits disease progression in patients with benign prostate hyperplasia.
Schwarz S; Obermüller-Jevic UC; Hellmis E; Koch W; Jacobi G; Biesalski HK
J Nutr; 2008 Jan; 138(1):49-53. PubMed ID: 18156403
[TBL] [Abstract][Full Text] [Related]
17. Prostate cells exposed to lycopene in vitro liberate lycopene-enriched exosomes.
Goyal A; Delves GH; Chopra M; Lwaleed BA; Cooper AJ
BJU Int; 2006 Oct; 98(4):907-11. PubMed ID: 16978292
[TBL] [Abstract][Full Text] [Related]
18. [Phytotherapy in urology. Current scientific evidence of its application in benign prostatic hyperplasia and prostate adenocarcinoma].
Morán E; Budía A; Broseta E; Boronat F
Actas Urol Esp; 2013 Feb; 37(2):114-9. PubMed ID: 23058996
[TBL] [Abstract][Full Text] [Related]
19. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis.
Gann PH; Ma J; Giovannucci E; Willett W; Sacks FM; Hennekens CH; Stampfer MJ
Cancer Res; 1999 Mar; 59(6):1225-30. PubMed ID: 10096552
[TBL] [Abstract][Full Text] [Related]
20. Lycopene/tomato consumption and the risk of prostate cancer: a systematic review and meta-analysis of prospective studies.
Chen J; Song Y; Zhang L
J Nutr Sci Vitaminol (Tokyo); 2013; 59(3):213-23. PubMed ID: 23883692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
